Decheng Capital Management Iii (Cayman), LLC Singular Genomics Systems, Inc. Transaction History

Decheng Capital Management Iii (Cayman), LLC

  • $181 Million
  • Q3 2023

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022
BUY
$5.94 - $12.09 $118,800 - $241,800
20,000 New
20,000 $126,000

Others Institutions Holding OMIC

# of Institutions
2
Shares Held
1.43M
Call Options Held
0
Put Options Held
0
View Full List

About Singular Genomics Systems, Inc.

OMIC Quotes by TradingView
  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $1.52B
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track This Portfolio

Track Decheng Capital Management Iii (Cayman), LLC Portfolio

Follow Decheng Capital Management Iii (Cayman), LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital Management Iii (Cayman), LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital Management Iii (Cayman), LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email